HF
BMRN icon

HRT Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History

HRT Financial’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,317
Closed -$2.57M – 2648
2025
Q1 		$2.57M Buy
36,317
+14,996
+70% +$1.01M 0.02% 707
2024
Q4 		$1.4M Buy
+21,321
New +$1.43M 0.01% 902
2024
Q2 		– Sell
-43,024
Closed -$3.76M – 2253
2024
Q1 		$3.76M Sell
43,024
-6,050
-12% -$542K 0.02% 353
2023
Q4 		$4.73M Buy
+49,074
New +$4.34M 0.03% 320
2023
Q2 		– Sell
-19,515
Closed -$1.9M – 2497
2023
Q1 		$1.9M Buy
+19,515
New +$2.02M 0.02% 623
2022
Q3 		– Sell
-7,385
Closed -$611K – 2819
2022
Q2 		$611K Buy
7,385
+4,449
+152% +$354K 0.01% 1341
2022
Q1 		$226K Buy
+2,936
New +$246K ﹤0.01% 2418
2021
Q3 		– Sell
-127,030
Closed -$10.6M – 3293
2021
Q2 		$10.6M Buy
+127,030
New +$10.1M 0.1% 174
2021
Q1 		– Sell
-131,636
Closed -$11.5M – 2703
2020
Q4 		$11.5M Buy
+131,636
New +$10.4M 0.23% 72
2019
Q4 		– Sell
-4,343
Closed -$292K – 1168
2019
Q3 		$292K Buy
4,343
+1,611
+59% +$124K 0.01% 953
2019
Q2 		$233K Buy
+2,732
New +$234K 0.01% 597
2015
Q4 		– Sell
-1,944
Closed -$204K – 69
2015
Q3 		$204K Buy
+1,944
New +$260K 0.17% 75

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's BMRN Position: Q2 2025 in Review

HRT Financial sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 36,317 shares — an estimated $2.57M sold.

HRT Financial first reported a position in BMRN in Q3 2015 and held it in 12 quarters. The position peaked at $11.5M in Q4 2020. 581 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.

  • HRT Financial reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 36,317 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $2.57M.
  • HRT Financial first reported a position in BioMarin Pharmaceuticals in Q3 2015 and held it in 12 quarters.
  • HRT Financial's BioMarin Pharmaceuticals position peaked at $11.5M in Q4 2020.
  • 581 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.